Literature DB >> 3679754

Influence of ethacrynic acid on outflow facility in the monkey and calf eye.

D L Epstein1, T F Freddo, S Bassett-Chu, M Chung, L Karageuzian.   

Abstract

Living monkeys were perfused via the anterior chamber by the two step constant pressure technique with the sulfhydryl (SH)-reactive diuretic, ethacrynic acid (ECA) at dosages from 0.1 to 1.0 mM. Above 0.37 mM a reproducible increase in outflow facility (C) was observed. At 0.5 mM C increased 115% with ECA compared to a 22% increase in control eyes (n = 9; P less than 0.01). In three monkeys simultaneous perfusion of ECA with cysteine in 10% excess prevented this effect. In enucleated calf eyes at dosages ranging from 0.1 to 0.5 mM ECA a similar increase in outflow facility was demonstrated. Simultaneous perfusion of 0.1 mM ECA with 0.5 mM cysteine blocked this increase in facility. At high dosages (6 mM) of ECA a decrease in C of 35% was observed (P less than 0.01, n = 8). Electron microscopic studies of the perfused monkey eyes did not readily explain the observed facility effects of ECA, except for the occurrence of a small number of breaks in the inner wall endothelium of Schlemm's canal. The juxtacanalicular meshwork appeared normal. Moderate to profound trabecular endothelial cell swelling was observed with ECA alone and with simultaneous cysteine. Morphologic studies performed 4 and 11 weeks after repetitive acute exposure to ECA indicated that the tissues of the outflow pathway appeared normal. The importance of this work is that it points to a new class of drugs that may be used someday to treat glaucoma.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3679754

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study.

Authors:  B E K Klein; R Klein; M D Knudtson
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

Review 2.  Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma.

Authors:  Megumi Honjo; Hidenobu Tanihara
Journal:  Jpn J Ophthalmol       Date:  2018-02-14       Impact factor: 2.447

Review 3.  Matricellular proteins in the trabecular meshwork: review and update.

Authors:  Ayan Chatterjee; Guadalupe Villarreal; Douglas J Rhee
Journal:  J Ocul Pharmacol Ther       Date:  2014-06-05       Impact factor: 2.671

Review 4.  Pharmacological advances in the treatment of glaucoma.

Authors:  J B Serle
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

5.  Effects of chemical inhibition of N-WASP, a critical regulator of actin polymerization on aqueous humor outflow through the conventional pathway.

Authors:  Toshihiro Inoue; Padmanabhan P Pattabiraman; David L Epstein; P Vasantha Rao
Journal:  Exp Eye Res       Date:  2009-12-02       Impact factor: 3.467

6.  Eyedrops containing SA9000 prodrugs result in sustained reductions in intraocular pressure in rabbits.

Authors:  John J Arnold; Yash Choksi; Xin Chen; Atsushi Shimazaki; John Hatten; Eric J Toone; David L Epstein; Pratap Challa
Journal:  J Ocul Pharmacol Ther       Date:  2009-06       Impact factor: 2.671

Review 7.  The role of the actomyosin system in regulating trabecular fluid outflow.

Authors:  Baohe Tian; B'Ann T Gabelt; Benjamin Geiger; Paul L Kaufman
Journal:  Exp Eye Res       Date:  2008-08-27       Impact factor: 3.467

8.  Cellular pharmacokinetic and pharmacodynamic analyses of ethacrynic acid: Implications in topical drug delivery in the eye.

Authors:  Cheng-Wen Lin; Pedro Gonzalez; Fan Yuan
Journal:  Mol Vis       Date:  2011-09-27       Impact factor: 2.367

Review 9.  Surgery on the Trabecular Meshwork: Histopathological Evidence.

Authors:  Shibal Bhartiya; Parul Ichhpujani; Tarek Shaarawy
Journal:  J Curr Glaucoma Pract       Date:  2015-09-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.